2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
T Palmerini, G Biondi-Zoccai, D Della Riva, C Stettler… - The Lancet, 2012 - thelancet.com
Background The relative safety of drug-eluting stents and bare-metal stents, especially with
respect to stent thrombosis, continues to be debated. In view of the overall low frequency of …
respect to stent thrombosis, continues to be debated. In view of the overall low frequency of …
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …
P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …
coronary intervention are of major importance, but a lack of standardization in defining this …
[HTML][HTML] Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Background Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the
standard of care after percutaneous coronary intervention (PCI) for patients with atrial …
standard of care after percutaneous coronary intervention (PCI) for patients with atrial …
Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) …
Y Morino, M Abe, T Morimoto, T Kimura… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: This study sought to establish a model for grading lesion difficulty in
interventional chronic total occlusion (CTO) treatment. Background: Owing to uncertainty of …
interventional chronic total occlusion (CTO) treatment. Background: Owing to uncertainty of …
Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients
M Nobuyoshi, T Kimura, H Nosaka, S Mioka… - Journal of the American …, 1988 - Elsevier
To further understand the temporal mode and mechanisms of coronary restenosis, 229
patients were studied by prospective angiographic follow-up on day 1 and at 1, 3 and 6 …
patients were studied by prospective angiographic follow-up on day 1 and at 1, 3 and 6 …
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …
H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation
T Kimura, T Morimoto, Y Nakagawa, T Tamura… - Circulation, 2009 - Am Heart Assoc
Background—The influences of antiplatelet therapy discontinuation on the risk of stent
thrombosis and long-term clinical outcomes after drug-eluting stent implantation have not yet …
thrombosis and long-term clinical outcomes after drug-eluting stent implantation have not yet …
Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry
T Kimura, T Morimoto, Y Nakagawa, K Kawai… - Circulation, 2012 - Am Heart Assoc
Background—There is a scarcity of long-term data from large-scale drug-eluting stent
registries with a large enough sample to evaluate low-frequency events such as stent …
registries with a large enough sample to evaluate low-frequency events such as stent …
Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage
Y Kuwabara, K Ono, T Horie, H Nishi… - Circulation …, 2011 - Am Heart Assoc
Background—Recently, elevation of circulating muscle-specific microRNA (miRNA) levels
has been reported in patients with acute myocardial infarction. However, it is still unclear …
has been reported in patients with acute myocardial infarction. However, it is still unclear …